Read twice and referred to the Committee on the Judiciary.
The Patients Over Profit (POP) Act would make it unlawful for a single person or entity to both (A) directly or indirectly own, operate, or control a health insurance issuer and (B) directly or indirectly own, operate, or control an "applicable provider" or a management services organization (MSO) that has a management services agreement with an applicable provider. The bill requires divestiture within set timelines (2 years for pre-enactment holdings; 1 year for post-enactment acquisitions), subject to tolling during Clayton Act/FTC review, and directs enforcement by the FTC, DOJ Antitrust Division, HHS Inspector General, and state attorneys general with injunctive relief and disgorgement paid into an FTC fund for harmed communities.
Scope and approach: Liberals view the bill as necessary structural reform to remove perverse incentives; conservatives view it as overbroad government intrusion rather than a proper antitrust tool.
Relative to its intended legislative type, this bill is a substantive statute that sets a clear legal prohibition and provides multiple enforcement tools and Medicare-specific implementation steps, while delegating important operational details to agencies.
The Patients Over Profit (POP) Act would make it unlawful for a single person or entity to both (A) directly or indirectly own, operate, or control a health insurance issuer and (B) directly or indirectly own, operate, or control an "applicable provider" or a management services organization (MSO) that has a management services agreement with an applicable provider.
The bill requires divestiture within set timelines (2 years for pre-enactment holdings; 1 year for post-enactment acquisitions), subject to tolling during Clayton Act/FTC review, and directs enforcement by the FTC, DOJ Antitrust Division, HHS Inspector General, and state attorneys general with injunctive relief and disgorgement paid into an FTC fund for harmed communities.
The measure amends Medicare Advantage and Part D authorities to bar the Secretary from contracting with MA organizations that have the prohibited common ownership and treats claims by entities in violation as false claims under federal law; it includes definitions and explicit exclusions for hospitals, critical access hospitals, rural emergency hospitals, pharmacies, and suppliers of durable medical equipment, prosthetics, orthotics, and supplies.
On content alone, this is a high-impact structural reform that would reorganize insurer–provider relationships nationwide and alter Medicare contracting. Historically, large market-structuring bills that impose mandatory divestiture and affect major industries face strong industry pushback, complex implementation and litigation risk, and difficulty securing the wide bipartisan support often required for enactment; the bill contains some transitional and carve-out features but lacks a sunset, pilot approach, or explicit funding/implementation detail that would reduce political resistance.
Relative to its intended legislative type, this bill is a substantive statute that sets a clear legal prohibition and provides multiple enforcement tools and Medicare-specific implementation steps, while delegating important operational details to agencies.
Scope and approach: Liberals view the bill as necessary structural reform to remove perverse incentives; conservatives view it as overbroad government intrusion rather than a proper antitrust tool.
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope and approach: Liberals view the bill as necessary structural reform to remove perverse incentives; conservatives view it as overbroad government intrusion rather than a proper antitrust tool.
A mainstream progressive would likely view the bill favorably as a measure to reduce financial conflicts of interest that arise when insurers and providers are commonly owned.
They would see it as strengthening antitrust enforcement in health care and protecting patients from profit-driven steering, upcoding, or denials.
They may, however, note some implementation and access risks — especially in underserved areas — and will look to the bill’s disgorgement and FTC review provisions as positive accountability tools.
A pragmatic, centrist observer would see legitimate consumer-protection and antitrust rationales in the bill but be cautious about operational details and unintended consequences.
They would appreciate the incorporation into Medicare Advantage and the FTC/DOJ review requirements, while worrying that forced divestitures and rigid prohibitions may destabilize integrated care arrangements that currently support coordination.
Centrists would want careful implementation, clear rules to avoid market disruption, and evidence that the benefits outweigh transition costs before full support.
A mainstream conservative would likely oppose the bill as an expansive regulatory intrusion into private markets and a restraint on business arrangements between insurers and providers.
They would view forced divestiture, disgorgement, and barring contracts with Medicare Advantage organizations as heavy-handed and likely to chill investment, reduce innovation in care models, and increase legal and administrative burdens.
Some conservatives who prioritize antitrust enforcement might accept targeted scrutiny of truly anticompetitive mergers, but would object to a broad statutory prohibition of common ownership of insurers and many providers.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, this is a high-impact structural reform that would reorganize insurer–provider relationships nationwide and alter Medicare contracting. Historically, large market-structuring bills that impose mandatory divestiture and affect major industries face strong industry pushback, complex implementation and litigation risk, and difficulty securing the wide bipartisan support often required for enactment; the bill contains some transitional and carve-out features but lacks a sunset, pilot approach, or explicit funding/implementation detail that would reduce political resistance.
The bill has not accumulated any surfaced votes yet.
Scope and approach: Liberals view the bill as necessary structural reform to remove perverse incentives; conservatives view it as overbroad…
On content alone, this is a high-impact structural reform that would reorganize insurer–provider relationships nationwide and alter Medicar…
Relative to its intended legislative type, this bill is a substantive statute that sets a clear legal prohibition and provides multiple enforcement tools and Medicare-specific implementation steps, while delegating impo…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.